Skip to main content

Wyeth Losing CFO Martin

He will leave in June.



said Friday that Chief Financial Officer and Vice Chairman Kenneth Martin will leave in June, adding to a string of CFO departures among Big Pharma companies in the last 12 months.

Martin, 53, who had been financial chief since 2000, will "pursue personal interests," Wyeth said in a brief press release. The company will name a new CFO before Martin leaves.

Lately, a number of chief financial officers have been exiting giant drugmakers for unspecified personal reasons or retirement. In February,


(MRK) - Get Merck & Co., Inc. Report

said Judy Lewent, 58, its CFO for 17 years, would retire in July.

After Lewent and Martin leave, no U.S. Big Pharma company will have had a CFO serving for more than five years. The longest-tenured CFO will be Andrew Bonfield, 44, of

Bristol-Myers Squibb

TheStreet Recommends

(BMY) - Get Bristol-Myers Squibb Company Report

, who started in September 2002.

Other recent changes in the CFO ranks include Dominic Caruso, who took over the job Jan. 1 at

Johnson & Johnson

(JNJ) - Get Johnson & Johnson Report

, succeeding Robert Darretta, who retired after nine years as CFO and 38 years at the company. Caruso had been vice president of J&J's group finance unit.


Eli Lilly

(LLY) - Get Eli Lilly and Company Report

, Derica Rice, formerly the controller, moved up to CFO 12 months ago when Charles Golden retired after serving 10 years as chief financial officer.